|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6100 USD | +1.67% |
|
-0.38% | -45.45% |
| 10/06 | OneMedNet Says 2026 New Bookings Exceed $3 Million | MT |
| 16/05 | OneMedNet Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Revenues | 10.92L | 11.53L | 10.22L | 6L | 13.59L | |
Total Revenues | 10.92L | 11.53L | 10.22L | 6L | 13.59L | |
Cost of Goods Sold, Total | 12.05L | 15.13L | 11.5L | 9L | 18.62L | |
Gross Profit | -1L | -4L | -1L | -3L | -5L | |
Selling General & Admin Expenses, Total | 19.54L | 48.03L | 66.15L | 78.57L | 76.49L | |
R&D Expenses | 6L | 10L | 16.32L | 14.67L | 15.15L | |
Other Operating Expenses, Total | 25.97L | 57.55L | 82.46L | 93.24L | 91.64L | |
Operating Income | -27.11L | -61.16L | -83.74L | -96.05L | -96.67L | |
Interest Expense, Total | -2L | -4L | -7L | -1L | -67T | |
Interest And Investment Income | - | - | - | - | - | |
Net Interest Expenses | -2L | -4L | -7L | -1L | -67T | |
Other Non Operating Income (Expenses) | -34.9T | -46.82T | -35.78L | -4L | 14.06L | |
EBT, Excl. Unusual Items | -29.41L | -65.66L | -1.27Cr | -1.01Cr | -83.28L | |
Asset Writedown | - | - | -1.05Cr | - | - | |
Other Unusual Items | - | - | - | - | 55.28L | |
EBT, Incl. Unusual Items | -29.41L | -65.66L | -2.32Cr | -1.01Cr | -28L | |
Income Tax Expense | - | - | - | 2T | 1T | |
Earnings From Continuing Operations | -29.41L | -65.66L | -2.32Cr | -1.01Cr | -28.01L | |
Net Income to Company | -29.41L | -65.66L | -2.32Cr | -1.01Cr | -28.01L | |
Net Income - (IS) | -29.41L | -65.66L | -2.32Cr | -1.01Cr | -28.01L | |
Net Income to Common Incl Extra Items | -29.41L | -65.66L | -2.32Cr | -1.01Cr | -28.01L | |
Net Income to Common Excl. Extra Items | -29.41L | -65.66L | -2.32Cr | -1.01Cr | -28.01L | |
Per Share Items | ||||||
Net EPS - Basic | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Basic EPS - Continuing Operations | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Basic Weighted Average Shares Outstanding | 1.5Cr | 45.6L | 2.36Cr | 2.81Cr | 4.45Cr | |
Net EPS - Diluted | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Diluted EPS - Continuing Operations | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Diluted Weighted Average Shares Outstanding | 1.5Cr | 45.6L | 2.36Cr | 2.81Cr | 4.45Cr | |
Normalized Basic EPS | -0.12 | -0.9 | -0.34 | -0.23 | -0.12 | |
Normalized Diluted EPS | -0.12 | -0.9 | -0.34 | -0.23 | -0.12 | |
Supplemental Items | ||||||
EBITDA | -26.96L | -60.91L | -83.46L | -95.48L | -96.02L | |
EBITA | -27.11L | -61.16L | -83.74L | -96.05L | -96.67L | |
EBIT | -27.11L | -61.16L | -83.74L | -96.05L | -96.67L | |
Total Revenues (As Reported) | - | - | - | 6L | 13.59L | |
Effective Tax Rate - (Ratio) | - | - | - | -0.02 | -0.04 | |
Normalized Net Income | -18.38L | -41.04L | -79.38L | -63.29L | -52.05L | |
Supplemental Operating Expense Items | ||||||
Selling and Marketing Expenses | 6L | 10L | 11.15L | 8L | 12.72L | |
General and Administrative Expenses | 11.97L | 34.46L | 52.74L | 70.27L | 63.77L | |
Research And Development Expense From Footnotes | 6L | 10L | 16.32L | 14.67L | 15.15L | |
Stock-Based Comp., COGS (Total) | - | - | - | - | 55T | |
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | 1L | |
Stock-Based Comp., S&M Exp. (Total) | - | - | - | - | 75T | |
Stock-Based Comp., G&A Exp. (Total) | - | 15.92L | - | - | 17.87L | |
Stock-Based Comp., Other (Total) | 97.87T | 7.71T | - | 1.47Cr | - | |
Total Stock-Based Compensation | 97.87T | 16L | - | 1.47Cr | 20.32L |
- Stock Market
- Stocks
- ONMD Stock
- Financials OneMedNet Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















